Wells Fargo’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254K Sell
92,880
-170,308
-65% -$539K ﹤0.01% 4562
2025
Q4
$974K Buy
263,188
+117,335
+80% +$379K ﹤0.01% 3993
2025
Q3
$387K Buy
145,853
+22,405
+18% +$43.3K ﹤0.01% 4482
2025
Q2
$122K Sell
123,448
-1,094,093
-90% -$1.1M ﹤0.01% 5082
2025
Q1
$1.75M Buy
1,217,541
+1,109,140
+1,023% +$2.04M ﹤0.01% 3267
2024
Q4
$238K Buy
108,401
+2,022
+2% +$4.72K ﹤0.01% 4686
2024
Q3
$176K Buy
106,379
+316
+0.3% +$638 ﹤0.01% 4673
2024
Q2
$235K Buy
106,063
+78,256
+281% +$184K ﹤0.01% 4414
2024
Q1
$74.5K Buy
27,807
+24,466
+732% +$59.5K ﹤0.01% 5064
2023
Q4
$9.99K Buy
3,341
+86
+3% +$112 ﹤0.01% 5837
2023
Q3
$3.19K Buy
3,255
+103
+3% +$149 ﹤0.01% 6024
2023
Q2
$4.38K Sell
3,152
-15,587
-83% -$21.8K ﹤0.01% 6092
2023
Q1
$29.8K Buy
18,739
+13,494
+257% +$69.7K ﹤0.01% 5450
2022
Q4
$32.7K Sell
5,245
-96
-2% -$687 ﹤0.01% 5051
2022
Q3
$36K Sell
5,341
-1,174
-18% -$8.06K ﹤0.01% 5096
2022
Q2
$41K Sell
6,515
-4,338
-40% -$24.6K ﹤0.01% 5114
2022
Q1
$50K Sell
10,853
-3,907
-26% -$16.8K ﹤0.01% 5658
2021
Q4
$74K Buy
14,760
+12,129
+461% +$97.1K ﹤0.01% 5779
2021
Q3
$31K Sell
2,631
-24,359
-90% -$355K ﹤0.01% 5805
2021
Q2
$572K Buy
26,990
+16,644
+161% +$401K ﹤0.01% 4548
2021
Q1
$290K Sell
10,346
-49,644
-83% -$1.46M ﹤0.01% 4982
2020
Q4
$1.56M Sell
59,990
-3,693
-6% -$111K ﹤0.01% 3669
2020
Q3
$2.37M Sell
63,683
-11,593
-15% -$459K ﹤0.01% 3179
2020
Q2
$3.86M Buy
75,276
+51,076
+211% +$2.14M ﹤0.01% 2725
2020
Q1
$762K Buy
24,200
+1,390
+6% +$73.4K ﹤0.01% 3721
2019
Q4
$1.36M Buy
22,810
+4,272
+23% +$192K ﹤0.01% 3638
2019
Q3
$680K Sell
18,538
-12,042
-39% -$477K ﹤0.01% 4144
2019
Q2
$1.42M Buy
30,580
+8,987
+42% +$422K ﹤0.01% 3625
2019
Q1
$868K Buy
21,593
+5,645
+35% +$253K ﹤0.01% 3987
2018
Q4
$733K Buy
15,948
+3,395
+27% +$164K ﹤0.01% 4079
2018
Q3
$557K Sell
12,553
-437,605
-97% -$20.1M ﹤0.01% 4355
2018
Q2
$17.6M Buy
450,158
+239,367
+114% +$12.1M 0.01% 1600
2018
Q1
$15.2M Buy
210,791
+200,695
+1,988% +$14.7M ﹤0.01% 1651
2017
Q4
$664K Sell
10,096
-4,423
-30% -$238K ﹤0.01% 4192
2017
Q3
$728K Buy
14,519
+2,917
+25% +$141K ﹤0.01% 4073
2017
Q2
$537K Hold
11,602
﹤0.01% 4176
2017
Q1
$410K Buy
11,602
+3,282
+39% +$75.2K ﹤0.01% 4375
2016
Q4
$104K Buy
8,320
+4,077
+96% +$48.5K ﹤0.01% 5129
2016
Q3
$59K Sell
4,243
-17,617
-81% -$200K ﹤0.01% 5219
2016
Q2
$216K Buy
21,860
+16,354
+297% +$271K ﹤0.01% 4369
2016
Q1
$93K Sell
5,506
-785
-12% -$12.6K ﹤0.01% 4879
2015
Q4
$140K Sell
6,291
-2,463
-28% -$62.1K ﹤0.01% 4693
2015
Q3
$206K Sell
8,754
-21,665
-71% -$1.36M ﹤0.01% 4451
2015
Q2
$2.49M Buy
30,419
+15,966
+110% +$1.56M ﹤0.01% 2930
2015
Q1
$1.34M Buy
14,453
+12,477
+631% +$805K ﹤0.01% 3328
2014
Q4
$80K Buy
1,976
+275
+16% +$8.42K ﹤0.01% 4832
2014
Q3
$41K Sell
1,701
-493
-22% -$7.83K ﹤0.01% 5003
2014
Q2
$35K Buy
2,194
+660
+43% +$9.54K ﹤0.01% 5106
2014
Q1
$23K Buy
1,534
+495
+48% +$7.68K ﹤0.01% 5184
2013
Q4
$15K Sell
1,039
-338
-25% -$4.92K ﹤0.01% 5086
2013
Q3
$26K Buy
+1,377
New +$23.1K ﹤0.01% 4885

Other funds holding ESPR